S. 2529 — 119th Congress
Federal bill
A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches.
- Title
- A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches.
- Type
- Senate bill
- Congress
- 119th Congress
- Chamber of origin
- Senate
- Introduced
- 2025-07-30
- Latest action
- Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- Latest action date
- 2025-07-30
Organizations that named this bill in federal lobbying filings
- CONSUMER HEALTHCARE PRODUCTS ASSOCIATION Federal lobbying client (LDA)
Federal lobbying filings naming this bill
U.S. Senate Lobbying Disclosure Act database. A filing names bills, issues and agencies — never the member lobbied — so these rows point only at the client organization, and none of them says any member of Congress was lobbied about this bill. The count is filings in this site's LDA slice, not the
- CONSUMER HEALTHCARE PRODUCTS ASSOCIATION cited in the filing's issue text 1 filing